Search Videos and More
Podcast
AFib, Episode 2: The Ablation Era
In the 2nd episode on atrial fibrillation with Dr. Steven Hoff and Dr. Mario Pascual, we are exploring surgical ablation, Endo/Epicardial Catheter approach for mapping and ablation of AF.
News
Neurologist G. Peter Gliebus, M.D., Joins Baptist Health
G. Peter Gliebus, M.D., a board-certified neurologist with subspecialty certification in behavioral neurology and neuropsychiatry, has joined Marcus Neuroscience Institute, part of Baptist Health, at Boca Raton Regional Hospital.
Podcast
TMS: Making Waves with Treatment Resistant Depression
Join doctors Michael McDermott, M.D. and Rachel Rohaidy, M.D., as they discuss Transcranial Magnetic Stimulation (TMS).
News
Miami Cancer Institute Leads First-in-World Brain Metastasis Trial
Baptist Health Miami Cancer Institute is leading a groundbreaking clinical trial that is studying the use of a new medication combined with stereotactic radiosurgery to combat metastatic brain cancer.
News
Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors
Researchers from Miami Cancer Institute, part of Baptist Health South Florida, recently published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The publication describes the current and potential impact of tissue-agnostic therapies on the management of PBTs. As part of the publication, the researchers discuss data from clinical trials of tissue-agnostic targets for PBTs in the context of challenges in managing these tumors. They also describe additional tissue-agnostic targets that hold promise for benefiting patients with PBTs.
News
Miami Cancer Institute Precision Oncology Symposium, Second Annual
Live Symposium Friday-Saturday, April 19-20, 2024 The Ritz-Carlton, Coconut Grove, Miami, Florida
News
Advanced Prostate Cancer: Genetic Testing an Invaluable Tool
A study led by Baptist Health Miami Cancer Institute shows that patients with TP53, RB1 and PTEN mutated prostate cancer have a lower overall survival rate than patients who are biomarker negative. The results emphasize the importance of genetic testing for all advanced cancer patients, the researchers say.
Video
Meet the Chief: John Uribe, M.D., Drives Evolution of Orthopedic Care
As head team physician for the Miami Dolphins and Florida Panthers and a lifelong athlete himself, John Uribe, M.D., admits he’s a bit of an adrenaline junkie. It’s a trait that has served him well in his storied career as an orthopedic surgeon with Baptist Health Orthopedic Care.
News
Cardiologist Lisa Weiss Forbess, M.D., Joins Miami Cardiac & Vascular Institute
Board-certified cardiologist Lisa Weiss Forbess, M.D., has joined Baptist Health Miami Cardiac & Vascular Institute.
News
Baptist Health Miami Cancer Institute First in U.S. to Offer New Robotic Technology for Liver Cancer
In May of 2023, Govindarajan Narayanan, M.D., became the first physician to use the Epione robot in the U.S., performing an image-guided microwave ablation on a patient with a liver tumor.
News
Miami Cancer Institute to Host Fifth Global Summit on Immunotherapies for Hematologic Malignancies
Miami Cancer Institute, part of Baptist Health South Florida, announced it will host the Fifth Annual Global Summit on Immunotherapies for Hematologic Malignancies, to be held March 8-9, 2024, at the JW Marriott Hotel in Brickell, Miami, Fla.
News
Miami Cancer Institute Achieves AAHRPP Accreditation
The Association for Accreditation of Human Research Protection Programs has recognized Miami Cancer Institute for promoting ethically sound and safe human subject research practices.